[EOHarm] 31 Avian and Pandemic Prototype Vaccines

[Guest guest]

Yes, and don't forget the movement to make flu vaccines mandatory for all health care workers!! (also supported by the government and being passed in some places already.) No matter which angle you look at this from, the situation with vaccines is out of hand and natural means of protection are being wiped out, totally ignored, and prevented from coming to the public view.

 

How do we hold these people accountable? Nothing is working and they are much more than asleep at the wheel!!!

 

Claudia

 

-

Diana Cregar

EOHarm ; Alternative_Medicine_For ; MedicalConspiracies@yah ; Health and Healing ; MagnesiumDistributors ; MagnesiumProfessionals ; MagnesiumForLife

Tuesday, May 02, 2006 3:04 PM

RE: [EOHarm] 31 Avian and Pandemic Prototype Vaccines

 

This is more disturbing...

 

http://tinyurl.com/oexm6 Federal Government Awards Sanofi Pasteur $100M Avian Flu Vaccine Contract. The contract calls for the company to manufacture the vaccine at a Pennsylvania facility for the 2008-2009 flu season.

 

http://tinyurl.com/h5njz AmeriCares Distributes Free Flu Vaccine to indigent populations. The vaccine was donated by Aventis Pasteur, which is located in Swiftwater, PA.

 

http://tinyurl.com/osbro AmeriCares: Nonprofit disaster relief charity, founded in 1982.

 

 

http://tinyurl.com/97c56 Senate Majority Leader Bill Frist and House Speaker Dennis Hastert engineered a backroom legislative maneuver to protect pharmaceutical companies from lawsuits.

 

http://tinyurl.com/pcsva The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law by President of the United States George W. Bush in December, 2005, is a a controversial tort liability shield intended to protect vaccine manufacturers from financial risk in the event of a declared public health emergency. The act specifically affords to drug makers immunity from potential financial liability for clinical trials of avian flu vaccine at the discretion of the Executive branch of gevernment.

 

 

http://tinyurl.com/9g4e3 A call by President George W. Bush for Congress to give him the power to use the military in law enforcement roles in the event of a bird flu pandemic has been criticized as akin to introducing martial law. Such a deadly event would raise difficult questions, such as how a quarantine might be enforced, the president said.

 

http://tinyurl.com/98ktc Martial Law and the Avian Flu Pandemic. What Bush's statements suggest is that Congress should enact legislation which will, in practice suspend Constituional government and allow the Military to intervene in civilian affairs in violation of the Posse Comitatus Act. The Posse Comitatus Act of 1878 bans the military from participating in police-type activity on U.S. soil. http://tinyurl.com/b3r7s

 

 

EOHarm [EOHarm ]On Behalf Of ClaudiaTuesday, May 02, 2006 12:49 PMAlternative_Medicine_For; MedicalConspiracies@yah; Health and Healing; MagnesiumDistributors; MagnesiumProfessionals; MagnesiumForLife; EOHarm Subject: [EOHarm] 31 Avian and Pandemic Prototype Vaccines

 

This is disturbing!!

 

http://www.medicalnewstoday.com/medicalnews.php?newsid=42537

 

 

There Are Thirty-One Avian & Pandemic Prototype VaccinesMain Category: Bird Flu / Avian Flu NewsArticle 02 May 2006 - 0:00am (PDT)The IFPMA's research-based vaccine manufacturing members are conducting a growing number of clinical trials of “prototoype” influenza vaccines, designed to counter to the threats of avian and pandemic influenza. “Industry is increasing its commitment to help minimize the global health impact of emerging influenza threats” said Dr. Harvey E. Bale, Director General of the IFPMA. “This is documented in the IFPMA summary ‘R & D for Avian / Pandemic Influenza Vaccines by IFPMA Influenza Vaccine Supply International Task Force (IVS ITF) members' published today.” This unique information resource lists all the prototype avian / pandemic influenza vaccines under development by these IFPMA member companies. As such, it covers the vast majority of R & D projects being undertaken in this field. (IFPMA = International Federation of Pharmaceutical Manufacturers & Associations)A total of 31 avian/pandemic prototype vaccine clinical trials are now listed by IFPMA, compared to 28 in January 2006. These vaccine trials involve 15 manufacturers, located in Australia, Austria, Canada, France, Germany, Italy, Japan, the Netherlands, Switzerland, UK and USA. sanofi pasteur alone has no less than eight different vaccine trials either recently completed or underway. A total of eleven Phase II clinical trials of prototype vaccines are either on-going or planned for 2006. Three prototype vaccines, one from Chiron / Novartis and two from GSK, have already been submitted as “Mock Up” dossiers for approval by the EU regulatory authority (EMEA). The majority of projects target specific strains of influenza virus (H2N2, H5N1, wild type H5N1, H5N3, H7N1, H7N7, H9N2), but Merck focuses on development of a universal influenza vaccine, using an M-2 peptide conjugate protein. Among the influenza strain-targeted projects, 26 use an inactivated virus (10 whole virus, 10 split virus, 6 surface antigen), and 4 use a live attenuated virus. Almost all prototype vaccines use a traditional injection delivery system, although MedImmune uses a nasal spray. Sixteen projects use Aluminum salt as an adjuvant. Berna/Crucell uses a virosome carrier/adjuvant system; CSL, Aluminum phosphate; Chiron/Novartis, MF59 and GSK, a novel adjuvant system. Twenty-five projects use the traditional egg culture technology currently used to manufacture seasonal influenza vaccines, while 6 use cell culture systems. About the IFPMA Influenza Vaccine Supply International Task ForceThe IFPMA Influenza Vaccine Supply Interventional Task Force (IVS ITF), established in February 2002, brings together research-based influenza vaccine manufacturers from around the world, which are conducting the R & D necessary to develop safe, effective, high-quality vaccines agains avian and pandemic influenza threats. The IVS ITF works within the constraints of anti-trust law to address the advocacy, communication, policymaking, regulatory, scientific and technical issues related to interpandemic and pandemic influenza vaccines. IVS ITF members are committed to make their unique expertise in R & D, logistics, manufacturing, safety and regulatory issues available to help governmental and intergovernmental bodies in pandemic planning and decisionmaking. For more information, see: ifpma.org/pdf/pandemic_backgrounder_23Jan06.pdf.About the IFPMAThe International Federation of Pharmaceutical Manufacturers & Associations is the global nonprofit NGO directly representing twenty-six research-based pharmaceutical, biotech and vaccine companies and sixty national industry associations in developed and developing countries. The industry's R & D pipeline contains hundreds of new medicines and vaccines being developed to address global disease threats, including cancer, heart disease, HIV/AIDS and malaria. The IFPMA Clinical Trials Portal and the IFPMA Health Partnerships Survey help make the industry's activities more transparent. The IFPMA strengthens patient safety by improving risk assessment of medicines and combating their counterfeiting. It also provides the secretariat for the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). http://www.ifpma.org